Methyldopa and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Methyldopa (methyldopa), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Acetylsalicylic Acid, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Methyldopa. It is created by eHealthMe based on reports of 6,345 people who have side effects when taking Methyldopa from the FDA, and is updated regularly.

What is Methyldopa?

Methyldopa has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 6,475 Methyldopa users. Check the latest studies of Methyldopa.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,956 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 15, 2026

6,345 people reported to have side effects when taking Methyldopa.
Among them, 99 people (1.56%) have Urinary tract infection.

Could Methyldopa cause Urinary tract infection?

Among these 99 people:

How long have people been on Methyldopa when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Methyldopa? *

female: 79.79 %
male: 20.21 %

What is the age of people who have Urinary tract infection when taking Methyldopa? *

What are other drugs people take besides Methyldopa? *

What are other side effects people have besides Urinary tract infection? *

Maternal Exposure During Pregnancy (use of substance during pregnancy): 41 people, 41.41%
Premature Delivery: 32 people, 32.32%
Oedema Peripheral (superficial swelling): 21 people, 21.21%
Premature Rupture Of Membranes: 20 people, 20.20%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 19 people, 19.19%
Live Birth: 19 people, 19.19%
Blood Albumin Decreased: 19 people, 19.19%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 19 people, 19.19%
Haematocrit Decreased: 19 people, 19.19%
Abdominal Distension: 19 people, 19.19%

What are the existing conditions these people have? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 19 people, 19.19%
High Blood Cholesterol: 19 people, 19.19%
Tocolysis (inhibition of uterine contractions): 15 people, 15.15%
Maternal Therapy To Enhance Foetal Lung Maturity: 15 people, 15.15%
Toxoplasmosis (a parasitic disease caused by the protozoan toxoplasma gondii): 13 people, 13.13%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 12 people, 12.12%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 9.09%
Pain: 7 people, 7.07%
Sle Arthritis (an autoimmune disease that causes your immune system to attack your body's own joints): 6 people, 6.06%
Dyspnea (difficult or laboured breathing): 4 people, 4.04%

* Approximation only. Some reports may have incomplete information.

Do you take Methyldopa and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methyldopa:

Methyldopa (6,475 reports)

Browse all side effects of Methyldopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,014 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,956 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methyldopa (the active ingredients of Methyldopa) and Methyldopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.